Zobrazeno 1 - 4
of 4
pro vyhledávání: '"T. V. Chernov"'
Autor:
O. V. Kutovaya, A. K. Tkhakakhova, S. A. Nikitina, A. D. Zhelezova, Natalya Xenofontova, T. V. Chernov, D. A. Nikitin, Mikhail Semenov
Publikováno v:
Eurasian Soil Science. 52:1414-1421
The seasonal dynamics of the structure of microbial biomass in a soddy-podzolic soil under fallow was assessed using luminescent microscopy. Samples from three soil horizons (P, 5‒15 cm, BEL, 30‒40 cm, and BT2, 50‒60 cm) were sampled monthly fr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82f18d6c49d2d823852263d5b602bec1
https://doi.org/10.1134/s1064229319110073
https://doi.org/10.1134/s1064229319110073
Autor:
Ya. Yu. Ilyina, E. V. Fot, N. N. Izotova, A. A. Smetkin, D. А. Volkov, E. A. Yakovenko, T. V. Chernova, V. V. Kuzkov, M. Yu. Kirov
Publikováno v:
Вестник анестезиологии и реаниматологии, Vol 15, Iss 6, Pp 10-19 (2019)
The endothelial glycocalyx (EG) system is an important protective regulator of vascular integrity and permeability, provides cellular interaction and serves as a component of hemostasis. Damage of EG in septic shock, cardiopulmonary bypass (CPB), tra
Externí odkaz:
https://doaj.org/article/25f85084f63e43608cfdf7f2327eda87
Autor:
O. O. Znoyko, M. V. Maevskaya, E. A. Klimova, S. L. Maksimov, S. N. Kizhlo, N. A. Petrochenkova, F. I. Nagimova, R. A. Ivanov, Yu. N. Linkova, T. V. Chernovskaya
Publikováno v:
Журнал инфектологии, Vol 5, Iss 1, Pp 83-90 (2014)
Algeron (cepeginterferon alfa-2b) is a new pegylated form of interferon alfa containing linear polyethylene glycol (molecular weight 20 kDa). Pharmacokinetic profile of Algeron allows once weekly administration. In phase II–III study 150 treatment-
Externí odkaz:
https://doaj.org/article/8309c85f05cb4ce69fe7e97dad55ad44
Autor:
M. V. Mayevskaya, O. O. Znoyko, E. A. Klimova, S. L. Maximov, S. N. Kizhlo, N. A. Petrochenkova, F. I. Nagimova, R. A. Ivanov, Yu. N. Linkova, T. V. Chernovskaya
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 23, Iss 1, Pp 30-36 (2013)
Aim of the study. To compare efficacy and safety of Algeron 1.5 and 2.0 μg/kg with PegIntron in combination with ribavirin in the treatment of chronic hepatitis C and to determine therapeutic dose of Algeron.Materials and Methods. 150 adult treatmen
Externí odkaz:
https://doaj.org/article/ba56af4b112c4c51b8bd662454878759